Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9184 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.902 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8926 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8831 |
High Similarity |
NPD7819 |
Suspended |
0.8824 |
High Similarity |
NPD7411 |
Suspended |
0.8776 |
High Similarity |
NPD1549 |
Phase 2 |
0.871 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8707 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8707 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8662 |
High Similarity |
NPD3749 |
Approved |
0.8636 |
High Similarity |
NPD4380 |
Phase 2 |
0.8616 |
High Similarity |
NPD6959 |
Discontinued |
0.8571 |
High Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8571 |
High Similarity |
NPD1510 |
Phase 2 |
0.8552 |
High Similarity |
NPD1240 |
Approved |
0.8544 |
High Similarity |
NPD7075 |
Discontinued |
0.8533 |
High Similarity |
NPD3750 |
Approved |
0.8514 |
High Similarity |
NPD6099 |
Approved |
0.8514 |
High Similarity |
NPD2796 |
Approved |
0.8514 |
High Similarity |
NPD6100 |
Approved |
0.8481 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8471 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8467 |
Intermediate Similarity |
NPD2800 |
Approved |
0.8435 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8408 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8366 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8323 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8313 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8289 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.828 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8278 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8258 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8239 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8232 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8232 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8224 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.82 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.82 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.82 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8188 |
Intermediate Similarity |
NPD6651 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8176 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8163 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8129 |
Intermediate Similarity |
NPD6799 |
Approved |
0.811 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD3226 |
Approved |
0.8084 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8084 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8027 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8026 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8025 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8013 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7987 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7974 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7962 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7929 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7908 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.787 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7853 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7852 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7848 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7836 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7824 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7821 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7821 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7811 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.78 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.78 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7771 |
Intermediate Similarity |
NPD2309 |
Approved |
0.777 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7764 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.775 |
Intermediate Similarity |
NPD5403 |
Approved |
0.775 |
Intermediate Similarity |
NPD920 |
Approved |
0.7733 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7722 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7697 |
Intermediate Similarity |
NPD943 |
Approved |
0.7688 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7682 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7677 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7677 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7677 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7677 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7671 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7661 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7654 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7654 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.764 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7627 |
Intermediate Similarity |
NPD4287 |
Approved |
0.7625 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7595 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7586 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7584 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7584 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7576 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7576 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7572 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7566 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7551 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7543 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7543 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7532 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7532 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7529 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD9717 |
Approved |
0.75 |
Intermediate Similarity |
NPD3972 |
Approved |
0.75 |
Intermediate Similarity |
NPD919 |
Approved |
0.75 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7471 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7471 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7471 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7446 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7434 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7423 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7418 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7418 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7416 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7412 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7405 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7389 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7377 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7351 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7351 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7351 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7349 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.732 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7318 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.731 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7305 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7299 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7297 |
Intermediate Similarity |
NPD17 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7278 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7255 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7238 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7237 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7234 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7232 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD411 |
Approved |
0.7225 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7216 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7205 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7197 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7197 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7196 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7196 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7188 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD8032 |
Phase 2 |
0.7171 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7161 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5889 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5890 |
Approved |
0.7135 |
Intermediate Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7134 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7134 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7134 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7134 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7102 |
Intermediate Similarity |
NPD5940 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7101
|
Intermediate Similarity |
NPD37 |
Approved |